Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes

BACKGROUND: Myelodysplastic syndromes (MDS) is a group of heterogeneous myeloid clonal diseases originating from hematopoietic stem cells. It has been demonstrated that apolipoproteins A1(ApoA1) are associated with disease risk in many cancer types. However, there still lacks evidence regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Cong, Gong, Shengping, Wu, An, Yang, Shujun, Zou, Duobing, Zhang, Yi, Wu, Ningning, Ma, Chao, Shi, Songqiu, Chen, Ying, Wu, Ying, Zheng, Xiaojiao, Huang, Zhenya, Ding, Jianghua, Ouyang, Guifang, Mu, Qitian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805344/
https://www.ncbi.nlm.nih.gov/pubmed/35100989
http://dx.doi.org/10.1186/s12885-022-09248-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805344/
https://www.ncbi.nlm.nih.gov/pubmed/35100989
http://dx.doi.org/10.1186/s12885-022-09248-2

Ejemplares similares